16:37 EDT Emergent BioSolutions sees Q3 revenue $210M-$250M, consensus $326.87M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EBS:
- Emergent BioSolutions Reports Financial Results for Second Quarter 2023
- Emergent BioSolutions eliminates COO role
- Emergent BioSolutions de-emphasizing focus on CDMO services, cuts 400 employees
- Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
- Biotech Alert: Searches spiking for these stocks today